Abiopharma

News list

Director Epstein Jeff 🟢 acquired 2.2K shares (1 derivative) of Zoom Communications, Inc. (ZM) Transaction Date: Aug 31, 2026 | Filing ID: 000130

Full text

News bot Sept. 2, 2026, 9:30 p.m.
🔍 Epstein Jeff (Director)

Company: Zoom Communications, Inc. (ZM)

Report Date: 2026-08-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 2,233
Detailed Transactions and Holdings:
- Acquired 2,233 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,233.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each Restricted Stock Unit represents a contingent right to receive one share of Issuer's Class A Common Stock.
- F2: The reporting person received an award of restricted stock units, 100% of which will vest on the first anniversary date of the grant (or, if sooner, the day immediately preceding the next annual meeting that occurs following the grant date).